Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


First Biotechnology Statistics Released

Modern Biotechnology Activity in New Zealand: Year ended June 1999

Statistics New Zealand today released the report Modern Biotechnology Activity in New Zealand. This is the first set of New Zealand statistics on modern biotechnology activity. The report analyses the results of a survey of 180 businesses and research institutions involved in modern biotechnology activity in the year ended June 1999. Statistics New Zealand is the fourth country in the OECD to produce statistics on modern biotechnology.

Modern biotechnology involves the application of modern scientific techniques to biological materials and processes. In New Zealand, modern biotechnology covers a range of activities, including the use of: the chemistry of DNA in health research and development of new varieties of trees and plants antibodies and enzymes in the development of vaccines biological material for pollution control biological materials in diagnostic testing in the provision of health services and the manufacture of food products. Traditional biotechnology processes, such as fermentation (eg beer brewing and bread making) and the use of oxidation ponds to treat sewage, were excluded from the survey coverage.

The results of the survey indicate the development of modern biotechnology in New Zealand is at an early stage. The majority of modern processes are used in research and development by enterprises. The primary focus is the development of new products and processes, or the adaptation of existing products and processes to suit New Zealand conditions.

The value of income associated with modern biotechnology is estimated to be $475 million in the year ended June 1999. The value of expenditure is estimated to be $405 million. To give some sense of the relative size of the modern biotechnology activity, the total income of the furniture manufacturing industry is $938 million. Total income from all manufacturing activity in 1999 is estimated to be $50.4 billion.

Enterprises in the survey reported employing 2,727 employees in activities associated with modern biotechnology. This represents 0.2 percent of total employment. Approximately 40 percent of those employed have post-graduate qualifications.

The period covered by the survey predates the voluntary moratorium on new trials of genetically modified products which started on 14 June 2000.

A copy of the report Modern Biotechnology Activity in New Zealand is available on the Statistics New Zealand website (, or on request from Statistics New Zealand.



© Scoop Media

Business Headlines | Sci-Tech Headlines


Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>


Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>